Sal-like protein 4 (SALL4), a stem cell biomarker in liver cancers-Reference-Cited by-同舟云学术

Sal-like protein 4 (SALL4), a stem cell biomarker in liver cancers

Published:2013-03-06 Issue:4 Volume:57 Page:1469-1483
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Oikawa Tsunekazu,Kamiya Akihide,Zeniya Mikio,Chikada Hiromi,Hyuck Ahn Dong,Yamazaki Yuji,Wauthier Eliane,Tajiri Hisao,Miller Lance D.,Wang Xin Wei,Reid Lola M.,Nakauchi Hiromitsu

Funder

Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology in Japan

Vertex Pharmaceuticals (Cambridge, MA)

Vesta Therapeutics (Bethesda, MD)

NCI

National Cancer Institute

American Cancer Society

Publisher

Wiley

Subject

Hepatology

Reference50 articles.

1. Global cancer statistics, 2002;Parkin;CA Cancer J Clin,2005

2. Stem cells, cancer, and cancer stem cells;Reya;Nature,2001

3. The biology of cancer stem cells;Lobo;Annu Rev Cell Dev Biol,2007

4. Side population purified from hepatocellular carcinoma cells harbors cancer stem cell-like properties;Chiba;HEPATOLOGY,2006

5. Histological and culture studies with respect to ABCG2 expression support the existence of a cancer cell hierarchy in human hepatocellular carcinoma;Zen;Am J Pathol,2007

Cited by 176 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cancer stem cells: advances in knowledge and implications for cancer therapy;Signal Transduction and Targeted Therapy;2024-07-05

2. SALL4 in gastrointestinal tract cancers: upstream and downstream regulatory mechanisms;Molecular Medicine;2024-04-08

3. Role of Cancer Stem Cells in Drug Resistance;Drug Resistance in Cancer: Mechanisms and Strategies;2024

4. Development of pre-clinical murine models for fibrolamellar hepatocellular carcinoma;2023-12-07

5. Down-Regulation of DHRS1 Predicts Poor Survival Outcome of Patients with Hepatocellular Carcinoma;IFMBE Proceedings;2023-10-19